KRON – kronos bio, inc. (US:NASDAQ)
Stock Stats
News
Kronos Bio, Inc. (NASDAQ: KRON) had its price target lowered by analysts at HC Wainwright from $2.50 to $2.25. They now have a "buy" rating on the stock.
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Kronos Bio (KRON) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]
Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]
Form ARS Kronos Bio, Inc. For: Dec 31
Form DEFA14A Kronos Bio, Inc.
Form DEF 14A Kronos Bio, Inc. For: Jun 25
Form S-8 Kronos Bio, Inc.
Form 10-K Kronos Bio, Inc. For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.